APR 24, 2020 1:44 AM PDT

Drug Targets Hard To Treat Uterine Cancer

WRITTEN BY: Nouran Amin

A clinical trial was deemed successful when evaluating a therapeutic for a hard-to-treat form of uterine cancer. The drug caused DNA damage inside tumors resulting in shrinkage for about one-third of patients.

“The preliminary results, to be presented online at Thursday's virtual session of the Society for Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer, demonstrated strong activity of WEE1-directed therapy in uterine serous carcinoma (USC), which accounts for about 10% of uterine cancers but up to 40% of deaths from the disease” trial leaders say.

The drug is called ‘adavosertib’ and works by stopping DNA from replicating in the tumor cells. Specifically, it targets a protein called WEE1 that is involved in the replication process. Some side-effects of the drug include anemia, diarrhea, nausea, and fatigue.

Learn more about uterine cancer (also known as endometrial cancer):

"Adavosertib demonstrated remarkable activity as a single agent in this group of patients," says the study's lead author, Joyce Liu, MD, MPH, of Dana-Farber. "It's especially encouraging in a disease such as USC, for which current treatments are of limited effectiveness."

The study involved 35 participants all of whom who underwent platinum-based chemotherapy.

“In some cases, the responses were exceptionally durable, with some patients still responding more than a year after undergoing treatment,” study leaders say.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 09, 2020
Drug Discovery & Development
APR 09, 2020
4 Natural Antihistamines with No Side Effects
Over-the-counter antihistamine treatments are known to be effective for relieving allergic symptoms. However, they are a ...
APR 11, 2020
Cardiology
APR 11, 2020
Cell Transplant Repairs Brain After Stroke
Using cell therapy, researchers from Lund University in Sweden have successfully restored mobility and a sense of touch ...
APR 13, 2020
Drug Discovery & Development
APR 13, 2020
Are COVID-19 Antibody Tests a Back-to-Work Pass?
Although treatments and vaccines against COVID-19 may still be months away, antibody tests are becoming more widespread. ...
APR 24, 2020
Drug Discovery & Development
APR 24, 2020
Teenage Cannabis Use May Prime the Brain to Enjoy Cocaine
New research has found that teenage cannabis use may make the brain more susceptible to the effects of cocaine. "It ...
APR 24, 2020
Drug Discovery & Development
APR 24, 2020
Combination Immunotherapy Allows Immune Cells To Target Tumors
A drug combination of immunotherapeutic agents encourages immune cells to devour cancer cells according to findings publ ...
MAY 13, 2020
Drug Discovery & Development
MAY 13, 2020
Fecal Transplant Helps Fight off Antibiotic Resistance
Fecal transplants work by transporting fecal matter from healthy donors to those who are less healthy. Now, a study has ...
Loading Comments...